The telemedicine market in the BRIC (Brazil, Russia, India and China) markets is witnessing a significant growth due to increase in the number of patients suffering from chronic diseases such as chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), asthma, hypertension, and diabetes, according to a new report added to the offering of Research and markets.
An increase in IT spending is identified as the key factor boosting demand for telemedicine in these countries. Moreover, increasing demand for better health care services and growth in telecommunication network are also impacting BRIC telemedicine market.
The BRIC telemedicine market is classified based on the type of technology and services used. Technology market can further be divided on hardware used and network connectivity solutions. Here basic telemedicine platform and clinical devices are the major hardware in use.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze